NCT06610162

Brief Summary

This study plans to learn more about why menopause increases the risk of weight gain. During and after menopause, women are prone to increased weight gain. The weight gained is primarily body fat, particularly visceral or abdominal body fat. The excess gain in abdominal fat during menopause increases the risk of chronic metabolic diseases such as heart disease and diabetes. The increase in weight and body fat with menopause may be due to changes in metabolism related to the loss of estrogen. This study plans to compare how the metabolism of premenopausal and postmenopausal women responds to changes in energy intake. The investigators will compare the changes in energy expenditure that occur during a period of acute fasting (24 hours) and a period of consuming excess calories (overfeeding).

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable obesity

Timeline
57mo left

Started Jan 2025

Longer than P75 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress22%
Jan 2025Dec 2030

First Submitted

Initial submission to the registry

September 18, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 24, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2029

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2030

Last Updated

April 30, 2025

Status Verified

September 1, 2024

Enrollment Period

5 years

First QC Date

September 18, 2024

Last Update Submit

April 25, 2025

Conditions

Keywords

energy expenditureadaptive thermogenesismenopause

Outcome Measures

Primary Outcomes (1)

  • Energy expenditure

    The number of calories burned over a set period of time

    24 hours

Secondary Outcomes (4)

  • Fibroblast growth factor 21 (FGF21)

    24 hours

  • 24 hour carbohydrate oxidation

    24 hours

  • 24 hour fat oxidation

    24 hours

  • 24 hour protein oxidation

    24 hours

Study Arms (2)

Premenopausal women

OTHER
Other: Eucalaloric feedingOther: Acute FastingOther: Acute Overfeeding

Postmenopausal women

OTHER
Other: Eucalaloric feedingOther: Acute FastingOther: Acute Overfeeding

Interventions

Participants will complete a 3-day diet run-in followed by an 24-hr in-patient visit in the room calorimeter. The energy content of the diet will be REE x 1.5 (30% fat, 55% carbohydrate, 15% protein). On the study day, will arrive at 7 AM and an IV catheter will be placed for blood draws, as described in the research plan. Participants will then enter the calorimeter at 0800, exit at 0700 the following day. Participants will be instructed to engage in primary sedentary behaviors. The energy content of the diet will be 1.3 x REE (\~30% fat, 55% carbohydrate, and 15% protein at each meal). Breakfast will account for \~25% and lunch and dinner \~30-35% of total energy needs. Meals will be provided at 0900, 1300, and 1800, and a light snack will be provided at 2000.

Postmenopausal womenPremenopausal women

Participants will complete a 3d diet run-in followed by an 24h in-patient visit in the room calorimeter. The energy content of the diet will be REE x 1.5 (30% fat, 55% carbohydrate, 15% protein). On the study day, will arrive at 7 AM and an IV catheter will be placed for blood draws, as described in the research plan. Participants will then enter the calorimeter at 0800, exit at 0700 the following day. Participants will be instructed to engage in primary sedentary behaviors. Participants will complete a 24 hour fast while in the calorimeter. They will be permitted to consume non-caloric beverages (i.e., water, non-caloric and non-caffeinated soft drinks, caffeine-free tea, or decaffeinated coffee) but refrain from consuming any caloric food or beverages. Upon exiting the calorimeter, participants will be provided a meal from the University of Colorado Hospital Patient Kitchen.

Postmenopausal womenPremenopausal women

Participants will complete a 3d diet run-in followed by an 24h in-patient visit in the room calorimeter. The energy content of the diet will be REE x 1.5 (30% fat, 55% carbohydrate, 15% protein). On the study day, will arrive at 7 AM and an IV catheter will be placed for blood draws, as described in the research plan. Participants will then enter the calorimeter at 0800, exit at 0700 the following day. Participants will be instructed to engage in primary sedentary behaviors. The energy content of the diet will be 200% of energy requirements, based on EE measured during the eucaloric condition. Macronutrient intake will be 3% protein, 51% carbohydrate, and 46% fat. Breakfast will account for \~25% and lunch and dinner \~30-35% of total energy needs. Meals will be provided at 0900, 1300, and 1800, and a light snack will be provided at 2000.

Postmenopausal womenPremenopausal women

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-45 years.
  • Regular menses (no missed cycles in the previous year; cycle length 25-35 d).
  • No menses for at least 12 months
  • Follicular stimulating hormone (FSH) ≥50 mIU/ml.
  • Women who are within 2 years of the final menstrual period are preferred

You may not qualify if:

  • Body mass index \> 30 kg/m2
  • Diabetes (fasting glucose \>126 mg/dL).
  • Thyroid dysfunction, defined as an ultrasensitive thyroid stimulating hormone (TSH) \<0.5 or \>5.0 mU/L
  • Uncontrolled hypertension defined as resting systolic BP \>150 mmHg or diastolic BP \>90 mmHg.
  • History or current use of estrogen-based hormonal therapy
  • Women who have undergone surgical menopause.
  • Current hormonal contraceptive use (past 6 mo.).
  • Pregnant, lactating, or intention to become pregnant during the study period.
  • Participants who fail the thyroid and BP criteria will be considered for enrollment if they receive treatment for these conditions and are considered stable by their treating physician.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Colorado Anschutz Medical Campus

Aurora, Colorado, 80045, United States

RECRUITING

MeSH Terms

Conditions

Obesity

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Edward L Melanson, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: This cross-sectional study will compare fasting and overfeeding effects on 24-hour EE and its components in pre- and postmenopausal women. We will study participants under three conditions in the room calorimeter: 1) eucaloric feeding (energy intake = EE); 2) acute, 24-hour fasting; and 3) acute, 24-hour overfeeding of a low-protein diet (i.e., 200% of energy requirements). Participants will complete the eucaloric study and then complete the overfeeding and fasting studies in random order. There will be a 1-4-week washout between conditions. Studies in premenopausal women will be performed during the mid-luteal phase (i.e., days 16-24) when both E2 and progesterone are elevated and, thus, when the potential hormonal effects are maximal.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2024

First Posted

September 24, 2024

Study Start

January 1, 2025

Primary Completion (Estimated)

December 31, 2029

Study Completion (Estimated)

December 31, 2030

Last Updated

April 30, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

The project will also produce data on the following: 24 h energy expenditure and substrate oxidation, body composition and visceral fat, laboratory screening measures, and blood and urine samples to measure changes in leptin, thyroid hormones, FGF21, catecholamines induced by each feeding condition. We will release summarized data and individual-level data that has been de-identified. 24-hour EE data will be summarized and released as minute-by-minute data

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data that can be shared will be made available at the time of associated publication(s) (data underlying peer-reviewed journal articles). Data that can be shared will be available for three years after completion of the project or after the last relevant publication, whichever is later.
Access Criteria
We will share data in a generalist repository as controlled access. Our institutional IRB does not allow public (open access) sharing of individual participant data. Only qualified individuals within the scientific community who request access to validate and replicate published research findings or perform analyses aligning with the approved protocol will receive repository access. Data users also agree not to share or redistribute any data downloads. Any publications or presentations that use the shared dataset must appropriately acknowledge the data source, list authors, and cite the associated publications. The requestor\'s institutional IRB or equivalent body must approve the requested use of the data. Data requestors must sign a data transfer agreement outlining the agreement with the above conditions to gain access

Locations